Tsuzuki S, Yasuda T, Goto H, Maeda N, Akahane K, Inukai T, Yamamoto H, Karnan S, Ota A, Hyodo T, Konishi H, Hosokawa Y, Kiyoi H, Hayakawa F. BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia. haematol [Internet]. 2022Aug.25 [cited 2023Sep.27];108(2):394-08. Available from: https://haematologica.org/article/view/haematol.2022.280879